BPC 157: Miracle Healing Peptide or Hidden Danger? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Warns Companies Illegally Marketing Products Containing 7 OH OncoDaily Peptides After Peptide Sciences Renew Vitality FDA Peptide Update: Category 2 Removals Explained